Galectin-3 modulates rat mesangial cell proliferation and matrix synthesis during experimental glomerulonephritis induced by anti-Thy1.1 antibodies

Journal of Pathology

Volumn 187, Issue 4, 1999, Pages 481-489

  Sasaki, Satoshi ^a,b   Bao, Qi ^a   Hughes, R Colin ^a  

^a NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

^b MEDICAL RESEARCH COUNCIL   (United Kingdom)

Author keywords

Cytokines; Galectins; Glomerulonephritis; Kidney; Mesangium

Indexed keywords

ANTIBODY; GALECTIN 3;

ALLERGIC GLOMERULONEPHRITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; EXTRACELLULAR MATRIX; MALE; MESANGIUM CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; RAT;

ANIMALS; ANTIGENS, DIFFERENTIATION; ANTIGENS, THY-1; AUTOANTIBODIES; BLOTTING, WESTERN; CELL CULTURE TECHNIQUES; CELL DIVISION; EXTRACELLULAR MATRIX; GALECTIN 3; GLOMERULAR MESANGIUM; GLOMERULONEPHRITIS, MEMBRANOPROLIFERATIVE; IMMUNOENZYME TECHNIQUES; MALE; MEMBRANE GLYCOPROTEINS; MICROSCOPY, FLUORESCENCE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0033020722     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199903)187:4<481::AID-PATH263>3.0.CO;2-2     Document Type: Article

References (52)

1. Barondes SH, Cooper DN, Gitt LA, Leffler H. Galectins. Structure and function of a large family of animal lectins. J Biol Chem 1994; 269: 20 807-20 810.
2. Hughes RC. Mac2: a versatile galactose-binding protein of mammalian tissues. Glycobiology 1994; 4: 5-12.
3. Perillo NL, Marcus ME, Baum LG. Galectins: versatile modulators of cell adhesion, cell proliferation and cell death. J Mol Med 1998; 76: 402-412.
4. Mehul B, Bawumia S, Martin SR, Hughes RC. Structure of baby hamster kidney carbohydrate binding protein CBP30, an S-type animal lectin. J Biol Chem 1994; 269: 18 250-18 258.
5. Lindstedt R, Apodaca G, Barondes SH, Mosto KE, Leffler H. Apical secretion of a cytosolic protein by Madin-Darby canine kidney cells. Evidence for polarized release of an endogenous lectin by a nonclassical secretory pathway. J Biol Chem 1993; 268: 11 750-11 757.
6. Sato S, Burdett I, Hughes RC. Secretion of the baby hamster kidney 30-kDa galactose-binding lectin from polarized and nonpolarized cells: a pathway independent of the endoplasmic reticulum-Golgi complex. Exp Cell Res 1993; 207: 8-18.
7. Mehul B, Hughes RC. Plasma membrane targeting, vesicular budding and release of galectin-3 from the cytoplasm of mammalian cells during secretion. J Cell Sci 1997; 110: 1169-1178.
8. Sato S, Hughes RC. Binding specificity of a baby hamster kidney lectin for H type I and II chains, polylactosamine glycans and appropriately glycosylated forms of laminin and fibronectin. J Biol Chem 1992; 267: 6983-6990.
9. Sato S, Hughes RC. Regulation of secretion and surface expression of Mac-2, a galactoside-binding protein of macrophages. J Biol Chem 1994; 269: 4424-4430.
10. Dong S, Hughes RC. Macrophage surface glycoproteins binding to galectin-3 (Mac-2 antigen). Glycocon J 1997; 14: 267-274.
11. Dong S, Hughes RC. Galectin-3 stimulates uptake of extracellular calcium in human Jurkat T-cells. FEBS Lett 1996; 395: 165-169.
12. Liu FT. S-type mammalian lectins in allergic inflammation. Immunol Today 1993; 14: 486-490.
13. Jeng KCG, Frigeri LG, Liu F-T. An endogenous lectin, galectin-3, potentiates IL-1 production by human monocytes. Immunol Lett 1994; 42: 113-116.
14. Kasper M, Hughes RC. Immunocytochemical evidence for a modulation of galectin-3, a carbohydrate binding protein, in pulmonary fibrosis. J Pathol 1996; 179: 309-316.
15. Winyard PJD, Bao Q, Hughes RC, Woolf AS. Epithelial galectin-3 during human nephrogenesis and childhood cystic diseases. J Am Soc Nephrol 1997; 8: 1647-1657.
16. Klahr S, Schreiner G, Ishikawa I. The progression of renal disease. N Engl J Med 1988; 318: 1657-1666.
17. Lan HY, Nikolic-Paterson DJ, Mu W, Atkins RC. Local macrophage proliferation in the pathogenesis of glomerular crescent formation in rat anti-glomerular basement (GBM) glomerulonephritis. Clin Exp Immunol 1997; 110: 233-240.
18. Bagchus WM, Hoedemaeker PJ, Rozing J, Bakker WW. Glomerulonephritis induced by monoclonal anti-Thy1.1 antibodies. A sequential histological and ultrastructural study in the rat. Lab Invest 1986; 55: 680-687.
19. Yamamoto T, Wilson CB. Complement dependence of antibody-induced mesangial injury in the rat. J Immunol 1987; 138: 3758-3765.
20. Striker GE, Striker LJ. Glomerular cell culture. Lab Invest 1985; 53: 123-128.
21. Yamamoto T, Noble NN, Miller DE, Border WA. Sustained expression of TGF-β underlies development of progressive kidney fibrosis. Kidney Int 1994; 45: 916-927.
22. Tesch GH, Lan HY, Atkins RC, Nikolic-Paterson DJ. Role of interleukin-1 in mesangial cell proliferation and matrix deposition in experimental mesangioproliferative nephritis. Am J Pathol 1997; 151: 141-150.
23. Border WA, Noble NN. Transforming growth factor β in tissue fibrosis. N Engl J Med 1994; 331: 1286-1292.
24. Damoiseaux JG, Dopp EA, Calame W, Chao D, MacPherson GG, Dijkstra CD. Rat macrophage lysosomal membrane antigen recognized by monoclonal antibody EDI. Immunology 1994; 83: 140-147.
25. Foddy L, Stamatoglou SC, Hughes RC. An endogenous carbohydrate-binding protein of baby hamster kidney cells. J Cell Sci 1990; 97: 139-148.
26. Johnson RJ, Iida H, Alpers CE, et al. Expression of smooth muscle cell phenotype by rat mesangial cells in immune complex nephritis; a-smooth muscle actin is a marker of mesangial cell proliferation. J Clin Invest 1991; 87: 847-858.
27. Haralson MA, Jacobson HR, Hoover RL. Collagen polymorphism in cultured rat kidney mesangial cells. Lab Invest 1987; 57: 513-523.
28. Ohyama K, Seyer JM, Raghow R, Kang AH. Extracellular matrix phenotype of rat mesangial cells in culture. Biosynthesis of collagen types I, III, IV and V and a low molecular weight collagenous component and their regulation by dexamethosone. J Lab Clin Med 1990; 116: 219-227.
29. Coimbra TR, Wiggins R, Noh JW, Merritt S, Phan SH. Transforming growth factor-β production in anti-glomerular basement disease in the rabbit. Am J Pathol 1991; 138: 223-234.
30. Sato S, Hughes RC. Control of Mac-2 surface expression on murine macrophage cell lines. Eur J Immunol 1994; 24: 216-221.
31. Miner JH, Sanes JR. Collagen IV a3, a4 and a5 chains in rodent basal laminae: sequence, distribution, association with laminins and developmental switches. J Cell Biol 1994; 127: 879-891.
32. Noakes PG, Miner JH, Gautam M, Cunningham JM, Sanes JR, Merlie JP. The renal glomerulus of mice lacking s-laminin β2:nephrosis despite molecular compensation by laminin β1. Nature Genet 1995; 10: 400-406.
33. Abrass CK, Spicer D, Berfield AK, St John P, Abrahamson DR. Diabetes induces changes in glomerular development and laminin-β (s-laminin) expression. Am J Pathol 1997; 151: 1131-1140.
34. Assad L, Schwartz MM, Virtanen I, Gould VE. Immunolocalization of tenascin and cellular fibronectins in diverse glomerulopathies. Virchows Arch B Cell Pathol Mol Pathol 1993; 63: 307-316.
35. Truong LD, Pindur J, Barrios R, et al. Tenascin is an important component of the glomerular extracellular matrix in normal and pathological conditions. Kidney Int 1994; 45: 201-210.
36. Probstmeier R, Montag D, Schachner M. Galectin-3, a β-galactoside-binding animal lectin, binds to neural recognition molecules. J Neurochem 1995; 64: 2465-2472.
37. Johnson RJ, Raines E, Floege J, Yoshimura A, Pritzi P, Ross R. Inhibition of mesangial cell proliferation and matrix expansion in glomerulonephritis in the rat by antibodies to platelet-derived growth factor. J Exp Med 1992; 175: 1413-1416.
38. Richardson CA, Gordon KL, Couser WG, Bomsztyk K. IL-1β increases laminin B2 chain mRNA levels and activates NF-kappa B in rat glomerular epithelial cells. Am J Physiol 1995; 268: F273-F278.
39. Torbohm I, Berger B, Sconermark M, von Kempis J, Rother K, Hansch GM. Modulation of collagen, synthesis in human glomerular epithelial cells by interleukin-1. Clin Exp Immunol 1989; 75: 427-431.
40. Liu FT, Hsu DK, Zuberi RI, Kuwabara I, Chi EY, Henderson WR. Expression and function of galectin-3, a beta-galactoside-binding lectin in monocytes and macrophages. Am J Pathol 1995; 147: 1016-1021.
41. Riser BL, Cortes P, Zhao X, Bernstein J, Dumier F, Narins RG. Intraglomerular pressure and mesangial stretching stimulate extracellular matrix formation in the rat. J Clin Invest 1992; 90: 1932-1943.
42. Bao Q, Hughes RC. Galectin-3 expression and effect on cyst enlargement and tubulogenesis in kidney epithelial MDCK cells cultured in three-dimensional matrices in vitro. J Cell Sci 1995; 108: 2791-2800.
43. Al-Awqati Q. Plasticity in epithelial polarity of renal intercalated cells: targeting of the H+/ATPase. Am J Physiol 1996; 270: C1571-C1580.
44. Wilson PD. Epithelial cell polarity and disease. Am J Physiol 1997; 272: F434-F442.
45. Mattana J, Singhal PC. Macrophage supernatants have both stimulatory and suppressive effects on mesangial cell proliferation. J Cell Physiol 1993; 154: 289-293.
46. Hebert E, Monsigny M. Galectin-3 mRNA level depends on transformation phenotype in ras-transformed NIH 3T3 cells. Biol Cell 1994; 81: 73-76.
47. Yang R-Y, Hsu DK, Liu F-T. Expression of galectin-3 modulates T-cell growth and apoptosis. Proc Natl Acad Sci USA 1996; 93: 6737-6742.
48. Lovett DH, Ryan JL, Sterzel RB. Stimulation of rat mesangial cell proliferation by macrophage interleukin-1. J Immunol 1983; 131: 2830-2836.
49. Werber HI, Emancipator SN, Tykocinski ML, Sedor JR. The interleukin-1 gene is expressed by rat glomerular mesangial cells and is augmented in immune complex glomerulonephritis. J Immunol 1987; 138: 3207-3212.
50. Baker AJ, Mooney A, Hughes J, Lombardi D, Johnson RJ, Savill J. Mesangial cell apoptosis: the major mechanism for resolution of glomerular hypercellularity in experimental mesangial proliferative nephritis. J Clin Invest 1994; 94: 2105-2166.
51. Gonzalez-Cuadrado S, Lopez-Armada C, Subira D, et al. Anti-Fas antibodies induce cytolysis and apoptosis in cultured human mesangial cells. Kidney Int 1996; 49: 1064-1070.
52. Kuncio GS, Neilson EG, Haverty T. Mechanisms of tubulointerstitial fibrosis. Kidney Int 1991; 39: 550-556.